Retinitis Pigmentosa (RP) (DBCOND0056216)

Identifiers

Synonyms
Retinitis Pigmentosa / RP (Retinitis Pigmentosa) / Pigmentary retinal dystrophy / Retinitis pigmentosa (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Vitamin A
A vitamin important for retinal function that is used clinically to correct vitamin A deficiency.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02617966
Rod and Cone Mediated Function in Retinal DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03281005
Development of Visual Function Evaluation MethodNo drug interventionsNot AvailableNot Availablecompleted
NCT03626207
Development of Visual Function Evaluation Method (2)No drug interventionsNot AvailableNot Availablecompleted
NCT03845218
Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome MeasuresNo drug interventionsNot AvailableNot Availablecompleted
NCT04120883
Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)treatment1 / 2terminated
NCT04765345
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1FNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05589714
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic VariantsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00378742
Repository for Inherited Eye DiseasesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01432847
Cell Collection to Study Eye DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04129021
High Resolution, High-speed Multimodal Ophthalmic ImagingNo drug interventionsotherNot Availablerecruiting
NCT04319809
Object Finder for a Retinal ProsthesisNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT05392751
Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosatreatment1 / 2terminated
NCT06319872
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients with Retinal Degenerationtreatment1not_yet_recruiting
NCT06628947
A Phase II Study of Intravitreal KIO-301 in Patients with Late-stage Retinitis Pigmentosatreatment2not_yet_recruiting
NCT03999021
FIGHT-RP 1 Extension Studytreatment1active_not_recruiting
NCT04141891
Advancing Understanding of Transportation OptionsNo drug interventionshealth_services_researchNot Availablecompleted
NCT06388200
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis PigmentosaNo drug interventionstreatment3recruiting
NCT06460844
Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa Patients (ENVISION)No drug interventionstreatment1recruiting
NCT04925687
Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosatreatment1completed
NCT05203939
Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosistreatment1 / 2active_not_recruiting
NCT05537220
Oral N-acetylcysteine for Retinitis Pigmentosatreatment3recruiting
NCT05748873
Promising ROd-cone DYstrophy Gene TherapYNo drug interventionstreatment1 / 2recruiting
NCT05853107
Pilot Study of AuTNA INo drug interventionstreatmentNot Availablerecruiting
NCT06517940
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)No drug interventionsNot AvailableNot Availablerecruiting
NCT02086890
Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis PigmentosaNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT06306690
Biomarkers in Retinitis PigmentosaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03063021
The FIGHT-RP1 Studytreatment1completed
NCT00407602
Argus® II Retinal Stimulation System Feasibility ProtocolNo drug interventionstreatmentNot Availablecompleted
NCT00804102
Transcorneal Electrical Stimulation Therapy for Retinal DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT05573984
Natural History of PRPF31 Mutation-Associated Retinal DystrophyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00661479
An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosatreatment1 / 2completed
NCT06242379
Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis PigmentosaNo drug interventionstreatment1 / 2recruiting
NCT05786287
Long-term Safety of UC-MSC Transplantation in Patients With Retinitis PigmentosaNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05914233
Non-invasive Ultrasound Retinal Stimulation for Vision RestorationNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03073733
Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosatreatment2completed
NCT00346333
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin Atreatment3completed
NCT03963154
Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic MutationNo drug interventionstreatment1 / 2active_not_recruiting
NCT04636853
CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degenerationtreatment3completed
NCT00001347
Study of Usher Syndromes, Type 1 and Type 2No drug interventionsNot AvailableNot Availablecompleted
NCT03635645
Experimental and Clinical Studies of Retinal StimulationNo drug interventionsotherNot Availablerecruiting
NCT00004345
Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher SyndromeNo drug interventionsNot AvailableNot Availableterminated
NCT04285398
Prospective Natural History Study of Retinitis PigmentosaNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT04909398
Pupil Dynamics and Color Vision for the Detection of Eye DiseasesNo drug interventionsotherNot Availablecompleted
NCT06574997
Expanded Access Program for RP in AdultsNot AvailableNot Availableavailable
NCT04558983
A Natural History Study to Evaluate Functional and Anatomical Progression in Retinitis PigmentosaNo drug interventionsNot AvailableNot Availablerecruiting
NCT00447993
A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosatreatment2completed
NCT01866371
High Resolution Retinal ImagingNo drug interventionsNot AvailableNot Availablerecruiting
NCT05909488
Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/IINo drug interventionstreatment2 / 3recruiting
NCT02303288
Post-Market Study of the Argus® II Retinal Prosthesis System - FranceNo drug interventionsNot AvailableNot Availablecompleted
NCT04224207
Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem CellsNo drug interventionstreatment3completed
NCT04068207
Minocycline Treatment in Retinitis Pigmentosatreatment2completed
NCT01604356
Acupuncture for the Treatment of Vision Loss Due to Retinitis PigmentosaNo drug interventionstreatment1completed
NCT06162585
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01560715
Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis PigmentosaNo drug interventionstreatment2completed
NCT01399515
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosatreatment2completed
NCT05258032
Structural and Functional Characterization of Rare Ocular DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT02759952
Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy TrialNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05820100
Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDTNo drug interventionsNot AvailableNot Availablecompleted
NCT03349242
Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)No drug interventionsNot AvailableNot Availablecompleted
NCT03629899
RETINA IMPLANT Alpha AMS in Blind Patients With Retinitis PigmentosaNo drug interventionstreatmentNot Availablewithdrawn
NCT05158049
Longitudinal Study of a Bionic EyeNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02465749
Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosatreatment0not_yet_recruiting
NCT02464436
Safety and Tolerability of hRPC in Retinitis PigmentosaNo drug interventionstreatment1 / 2active_not_recruiting
NCT05285618
The Perceptual Experience of Argus II UsersNo drug interventionsbasic_scienceNot Availablecompleted
NCT03011541
Stem Cell Ophthalmology Treatment Study IINo drug interventionstreatmentNot Availablerecruiting
NCT00345917
Safety Study in Retinal Transplantation for Retinitis Pigmentosa.No drug interventionstreatment2completed
NCT00559234
Potential Research Participants for Future Studies of Inherited Eye DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT04356716
Sildenafil for Treatment of Choroidal Ischemiatreatment2active_not_recruiting
NCT00000116
Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin ANo drug interventionstreatment3completed
NCT02244996
Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium BarbarumNo drug interventionstreatmentNot Availablecompleted
NCT04238858
Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis PigmentosatreatmentNot Availablecompleted
NCT04805658
Natural History Study of Retinitis Pigmentosa Type 11No drug interventionsNot AvailableNot Availablerecruiting
NCT02280135
Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis PigmentosaNo drug interventionstreatment1completed
NCT03381235
Exercise and RP (AVAMC and Emory)No drug interventionspreventionNot Availablecompleted
NCT06375239
Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Retinitis Pigmentosa PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02110225
A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)treatment1 / 2completed
NCT00100230
DHA and X-Linked Retinitis Pigmentosaprevention2completed
NCT03328130
Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B GeneNo drug interventionstreatment1 / 2recruiting
NCT01531348
Intravitreal Injection of MSCs in Retinitis PigmentosaNo drug interventionsother1completed
NCT02309866
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT02609165
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edematreatment2completed
NCT01847365
TES for the Treatment of RPNo drug interventionstreatmentNot Availablecompleted
NCT04919473
Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis PigmentosaNo drug interventionstreatment1 / 2completed
NCT00004827
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis PigmentosatreatmentNot Availablecompleted
NCT01490827
Argus® II Retinal Prosthesis System Post-Market Surveillance StudyNo drug interventionsNot AvailableNot Availableterminated
NCT04620876
Bimodal and Coaxial High Resolution Ophtalmic ImagingNo drug interventionsotherNot Availablerecruiting
NCT02709876
Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis PigmentosaNo drug interventionstreatment1 / 2unknown_status
NCT02804360
Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective StudyNo drug interventionstreatment2unknown_status
NCT05841862
Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM)No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05921162
A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal InjectionNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02670980
Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal DystrophyNo drug interventionstreatmentNot Availablecompleted
NCT02014389
Evaluation of Objective Perimetry Using Chromatic Multifocal PupillometerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01860092
New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis SystemNo drug interventionsNot AvailableNot Availableterminated
NCT02926092
Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)No drug interventionsNot AvailableNot Availableterminated
NCT02837640
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosatreatment2unknown_status
NCT01837901
Transcorneal Electrostimulation for Therapy of Retinitis PigmentosaNo drug interventionstreatmentNot Availablecompleted
NCT04295304
NR600 System Retinal Prosthesis for Patients With Retinal Degenerative DiseasesNo drug interventionstreatmentNot Availableterminated
NCT04945772
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]No drug interventionstreatment2completed
NCT02548572
Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter StudyNo drug interventionstreatmentNot Availablewithdrawn
NCT01680510
The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella BardawilNo drug interventionstreatment1 / 2active_not_recruiting
NCT01786395
Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosatreatment3terminated
NCT00000114
Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosatreatment3completed
NCT00515814
Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptorsNo drug interventionstreatmentNot Availablecompleted
NCT01949623
Biomarkers In Retinitis Pigmentosa (BIRP)No drug interventionsNot AvailableNot Availablecompleted
NCT04359108
Environmental Localization Mapping and Guidance for Visual Prosthesis UsersNo drug interventionsbasic_scienceNot Availablerecruiting
NCT03772938
Stem Cells Therapy in Degenerative Diseases of the RetinaNo drug interventionsother1unknown_status
NCT01024803
Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind PatientsNo drug interventionstreatmentNot Availablecompleted
NCT04611503
PDE6A Gene Therapy for Retinitis PigmentosaNo drug interventionstreatment1 / 2active_not_recruiting
NCT05085964
An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosatreatment2terminated
NCT02140164
Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosatreatment1 / 2completed
NCT01835002
Transcorneal Electrical Stimulation - Multicenter Safety StudyNo drug interventionstreatmentNot Availablecompleted
NCT03998384
A New Treatment of Retinitis PigmentosaNo drug interventionstreatmentNot Availableunknown_status
NCT05392179
A Study in Subjects With Retinitis PigmentosaNo drug interventionstreatment2completed
NCT01497379
Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind PatientsNo drug interventionstreatmentNot Availablecompleted
NCT05849987
In Depth Observational Clinical Trial Of Retinitis Pigmentosa PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00475254
Stress and Vision Fluctuations in Retinitis PigmentosaNo drug interventionsNot AvailableNot Availablecompleted
NCT02614651
AUgmented REality for the Visually Impaired - Part 1No drug interventionsbasic_scienceNot Availablecompleted
NCT05282953
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)treatment1 / 2recruiting
NCT01415453
Evoked Retinal ResponseNo drug interventionsNot AvailableNot Availableterminated
NCT00433277
Autoimmunity in Retinitis PigmentosaNot AvailableNot Availableunknown_status
NCT01876147
Visual and Functional Assessment in Low Vision PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00254605
Retinal Imaging in Patients With Inherited Retinal DegenerationsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01256697
The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis PigmentosaNo drug interventionstreatmentNot Availablecompleted
NCT03444961
Computer-Assisted Rehabilitation Environment Training After Argus Retinal ProsthesisNo drug interventionstreatmentNot Availablecompleted
NCT01068561
Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis PigmentosaNo drug interventionstreatment1completed
NCT02661711
Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Studytreatment2completed
NCT04284293
CNS10-NPC for the Treatment of RPNo drug interventionstreatment1recruiting
NCT00016471
A Genetic Analysis of Usher Syndrome in Ashkenazi JewsNo drug interventionsNot AvailableNot Availablecompleted
NCT04008771
Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal DiseasesNo drug interventionsotherNot Availablecompleted
NCT03248388
Argus II/ORCAM Device StudyNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT05805007
Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis PigmentosaNo drug interventionstreatment0recruiting
NCT01233609
Trial of Oral Valproic Acid for Retinitis Pigmentosatreatment2completed
NCT03078309
The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patientsbasic_science0unknown_status
NCT02909985
Visual Activity Evoked by Infrared in Humans After Dark AdaptationNo drug interventionsdiagnosticNot Availablecompleted
NCT05793515
Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo ModelsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05355415
Adaptive Optics Imaging of Outer Retinal DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04281732
Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced VisionNo drug interventionsNot AvailableNot Availableunknown_status
NCT00279500
Feasibility Study of a Chronic Retinal Stimulator in Retinitis PigmentosaNo drug interventionstreatmentNot Availablecompleted
NCT01530659
Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosatreatment2completed
NCT01736059
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for RetinopathyNo drug interventionstreatment1active_not_recruiting
NCT00458575
A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosatreatment1terminated
NCT06368375
Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis PigmentosaNo drug interventionsNot AvailableNot Availablecompleted
NCT04604899
Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosatreatment2completed
NCT04127006
Rate of Progression in EYS Related Retinal DegenerationNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01999049
Observational Study of the Argus® II Retinal Prosthesis SystemNo drug interventionsNot AvailableNot Availableunknown_status
NCT01914913
Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis PigmentosaNo drug interventionstreatment1 / 2unknown_status
NCT05176717
Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)treatment2 / 3terminated
NCT04252534
Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich PlasmatreatmentNot Availablecompleted
NCT03319524
Clinical and Genetic Testing of Patients With Usher SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT03406416
Study of a Suprachoroidal Retinal ProsthesisNo drug interventionstreatmentNot Availablecompleted
NCT03418116
Argus II Retinal Prosthesis System - Better Vision RP StudyNo drug interventionstreatmentNot Availablewithdrawn
NCT05158296
Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)treatment2 / 3terminated
NCT04864496
Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosatreatment2unknown_status
NCT03057496
Collision Warning Device for Blind and Visually ImpairedNo drug interventionsotherNot Availablecompleted
NCT01790958
Microcurrent Stimulation to Treat Macular DegenerationNo drug interventionsNot AvailableNot Availablecompleted
NCT06291935
Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 GeneNo drug interventionstreatment1recruiting
NCT00461435
Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis PigmentosaNo drug interventionsNot AvailableNot Availablecompleted
NCT05809635
Study of BEST1 Vitelliform Macular DystrophyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01864486
Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal DystrophyNo drug interventionstreatmentNot Availablecompleted
NCT03944239
Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis PigmentosaNo drug interventionsother1unknown_status
NCT04315025
Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis PigmentosaNo drug interventionstreatment1 / 2completed
NCT02588430
PMCF Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMSNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03322930
Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)No drug interventionsNot AvailableNot Availablecompleted
NCT05413148
The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis PigmentosaNo drug interventionstreatment2 / 3unknown_status
NCT05712148
Spheroidal Mesenchymal Stem Cells in Retinitis PigmentosaNo drug interventionssupportive_care1 / 2completed
NCT03374657
A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis PigmentosaNo drug interventionstreatment1 / 2active_not_recruiting
NCT03780257
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Genetreatment1 / 2completed
NCT00063765
Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eyetreatment1completed
NCT06076720
Evaluation of New Head-mounted Visual Aids Among Patients With Low VisionNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02860520
Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing.No drug interventionsNot AvailableNot Availablerecruiting
NCT01021982
Evaluation of Objective Perimetry Using PupillometerNo drug interventionsNot AvailableNot Availablecompleted
NCT04278131
BS01 in Patients With Retinitis PigmentosaNo drug interventionstreatment1 / 2recruiting
NCT03990727
Phenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies.No drug interventionsNot AvailableNot Availablerecruiting
NCT01603576
Pilot Study of a Suprachoroidal Retinal ProsthesisNo drug interventionstreatmentNot Availablecompleted
NCT04723160
Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus PhotographNo drug interventionsNot AvailableNot Availablecompleted
NCT04448860
Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life ActivitiesNo drug interventionsotherNot Availableunknown_status
NCT03901391
Prospective Open Clinical and Genetic Study of Patients With Retinitis PigmentosaNo drug interventionsNot AvailableNot Availablecompleted
NCT01505062
Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1Btreatment1 / 2terminated
NCT00427180
IRIS PILOT - Extended Pilot Study With a Retinal Implant SystemNo drug interventionstreatmentNot Availableunknown_status
NCT00447980
A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosatreatment2completed
NCT00717080
The Role of Capsular Tension Ring (CTR) in Anterior Capsular ContractionNo drug interventionstreatment4completed
NCT00029289
Effects of Lutein in Retinitis Pigmentosatreatment1 / 2completed
NCT02018692
The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis PigmentosaNo drug interventionstreatment1 / 2not_yet_recruiting
NCT04820244
Characterizing Rate of Progression in USHer Syndrome (CRUSH) StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02435940
Inherited Retinal Degenerative Disease RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT02720640
Safety and Efficacy of the Alpha AMS Subretinal ImplantNo drug interventionstreatmentNot Availablecompleted
NCT05800301
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and MagnovisionNo drug interventionssupportive_care3completed
NCT05147701
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye DiseasesNo drug interventionstreatment1recruiting
NCT00784901
Study of the Correlation Between Macular Thickness Analyzed by Optical Coherence Tomography and the Visual Functions in Retinitis PigmemtosaNo drug interventionsNot AvailableNot Availablecompleted
NCT06323772
Natural History Study in Patients With PDE6A-, PDE6B- and RHO-linked Retinitis PigmentosaNo drug interventionsNot AvailableNot Availablerecruiting
NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordNo drug interventionsNot AvailableNot Availablerecruiting
NCT00231010
Molecular Genetics of Retinal DegenerationsNo drug interventionsNot AvailableNot Availablecompleted
NCT01482195
Trial of Subretinal Injection of (rAAV2-VMD2-hMERTK)No drug interventionstreatment1completed
NCT04983914
Retrospective NIS to Evaluate the Patient Benefit of TESNo drug interventionsNot AvailableNot Availablecompleted
NCT06224114
Coloured-light in Retinitis Pigmentosa.No drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT00065455
Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosatreatment1completed
NCT04128150
High Resolution Retina ImagingNo drug interventionsNot AvailableNot Availableunknown_status
NCT06292650
Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa PatientsNo drug interventionstreatment0recruiting
NCT04234438
Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow LaserNo drug interventionstreatmentNot Availablecompleted
NCT00106743
Natural History and Genetic Studies of Usher SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT06627179
Study to Evaluate Ultevursen in Subjects with Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Genetreatment2not_yet_recruiting
NCT01543906
Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)treatment1completed
NCT02575430
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRATNo drug interventionsNot AvailableNot Availablecompleted
NCT04763369
Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP)No drug interventionstreatment2unknown_status
NCT02320812
Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosatreatment1 / 2completed
NCT03975543
Retrospective Natural History Study of Retinitis PigmentosaNo drug interventionsNot AvailableNot Availableunknown_status
NCT01014052
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutationstreatment1completed
NCT01521793
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)treatment1completed